Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 23, 2015, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $987.00 to $64,149,572.70.

Highlighted Stocks Traded by Insiders:

CSG Systems International (CSGS) - FREE Research Report

Wiese Randy, who is Evp & Cfo at CSG Systems International, sold 2,000 shares at $29.48 on March 23, 2015. Following this transaction, the Evp & Cfo owned 151,324 shares meaning that the stake was reduced by 1.3% with the 2,000-share transaction.

The shares most recently traded at $30.50, up $1.02, or 3.34% since the insider transaction. Historical insider transactions for CSG Systems International go as follows:

  • 4-Week # shares sold: 56,543
  • 12-Week # shares sold: 60,563
  • 24-Week # shares sold: 100,563

The average volume for CSG Systems International has been 274,000 shares per day over the past 30 days. CSG Systems International has a market cap of $1.0 billion and is part of the technology sector and computer software & services industry. Shares are up 20.78% year-to-date as of the close of trading on Monday.

CSG Systems International, Inc. provides business support solutions primarily to the communications industry. The stock currently has a dividend yield of 2.32%. The company has a P/E ratio of 27.5. Currently, there are 2 analysts who rate CSG Systems International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSGS - FREE

TheStreet Quant Ratings

rates CSG Systems International as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

CSG Systems International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

KCG Holdings (KCG) - FREE Research Report

Daniel V. Tierney 2011 Trust, who is 10% Owner at KCG Holdings, sold 48,419 shares at $12.52 on March 23, 2015. Following this transaction, the 10% Owner owned 8.8 million shares meaning that the stake was reduced by 0.55% with the 48,419-share transaction.

The shares most recently traded at $12.56, up $0.04, or 0.35% since the insider transaction.

The average volume for KCG Holdings has been 311,300 shares per day over the past 30 days. KCG Holdings has a market cap of $1.5 billion and is part of the financial sector and financial services industry. Shares are up 8.24% year-to-date as of the close of trading on Monday.

KCG Holdings, Inc., an independent securities firm, provides various services designed to address trading needs across asset classes, product types, and time zones. The company operates through three segments: Market Making, Global Execution Services, and Corporate and Other. The company has a P/E ratio of 23.4. Currently, there are 2 analysts who rate KCG Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KCG - FREE

TheStreet Quant Ratings

rates KCG Holdings as a

sell

. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and relatively poor performance when compared with the S&P 500 during the past year. Get the full

KCG Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ADMA Biologics (ADMA) - FREE Research Report

Lenz Brian, who is Chief Financial Officer at ADMA Biologics, bought 750 shares at $8.95 on March 23, 2015. Following this transaction, the Chief Financial Officer owned 5,000 shares meaning that the stake was boosted by 17.65% with the 750-share transaction.

The shares most recently traded at $12.00, up $3.05, or 25.4% since the insider transaction. Historical insider transactions for ADMA Biologics go as follows:

  • 4-Week # shares bought: 7,300
  • 12-Week # shares bought: 7,300
  • 24-Week # shares bought: 7,300

The average volume for ADMA Biologics has been 7,200 shares per day over the past 30 days. ADMA Biologics has a market cap of $116.1 million and is part of the health care sector and drugs industry. Shares are up 60.26% year-to-date as of the close of trading on Friday.

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases.

Exclusive Offer: Get the latest Stock Analysis on ADMA - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null